← Eichor
Study identifier: NCT06523582 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Condition: Neuroendocrine Neoplasm · Neuroendocrine Neoplasm of Gastrointestinal Tract · Neuroendocrine Neoplasm of Lung  ·  Sponsor: Universidad Nacional Autonoma de Mexico

PhaseN/A
Planned participants750
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Neuroendocrine neoplasms (NENs) are a heterogeneous group of lesions derived from cells with the ability to produce hormones that may arise from multiple different organs. Their clinical behavior is quite variable, encompassing both benign lesions and aggressive tumors that invade surrounding and/or distant structures. NENs may also cause serious morbidity due to hormone oversecretion. NENs are among the most frequently inherited human tumors, presenting either isolated or as part of syndromes in which a single patient or family develops multiple tumors. There are also non-inherited changes in the genetic information of the tumor cells that are potential targets for treatment. Both inherited and non-inherited DNA defects can be identified using modern routine genetic tests which, unfortunately, are not widely available in Mexico. This project seeks to uncover the genetic defects causing NENs in a large cohort of Mexican patients, using three different methods for genetic testing. Adult individuals with various types of NENs from two reference hospitals in Mexico City will be invited to participate. After completing informed consent, blood and, if possible, tissue samples will be obtained from all participants. Clinical details, laboratory results, imaging studies, and histopathological data at disease presentation will be retrieved. An initial screening will be performed by analyzing changes in the sequence of multiple genes that have been associated with the occurrence of …

This description comes directly from the study's public registry record.

Talk to the study team

Laura C Hernández Ramírez, MD, PhD  ·  +525554870900  ·  laura.hernandez@cic.unam.mx

Claudia Ramírez Rentería, MD, MSc  ·  +525556276900  ·  clau.r2000@gmail.com

Always discuss trial participation with your own doctor first.

Locations (3)

Hospital de Especialidades, Centro Médico Nacional Siglo XXI, Instituto Mexicano del Seguro SocialMexico City, Mexico City, MexicoRecruiting
Instituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico City, Mexico City, MexicoRecruiting
Red de Apoyo a la Investigación, Coordinación de la Investigación Científica, Universidad Nacional Autónoma de MéxicoMexico City, Mexico City, MexicoRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06523582